Novartis Bioventures Ltd, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), sold 39,294 shares at $23.47 ($919K) on 2017-06-02, disclosed to the SEC on 2017-06-06.
Open-market sale of $919k RARX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.47 | 14,867 | $349K | 38.0% |
| 2 | $23.47 | 14,867 | $349K | 38.0% |
| 3 | $23.11 | 4,780 | $110K | 12.0% |
| 4 | $23.11 | 4,780 | $110K | 12.0% |
| Total | $23.38 avg | 39,294 | $919K | 100% |
| Filing → |
| GRTX | SELL | 2020-06-04 | $251K | — | Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-15 | $185K | — | Filing → |